van der Veen J P, Goldschmeding R, Miedema F, Smit J W, Melief C J, von dem Borne A E
Br J Haematol. 1986 Dec;64(4):777-87. doi: 10.1111/j.1365-2141.1986.tb02240.x.
The role of humoral immune mechanisms in the pathogenesis of the neutropenia in five patients with chronic killer (K)-cell lymphocytosis was studied. For the detection of neutrophil antibodies in the patient's blood, immunofluorescence, cytotoxicity and agglutination tests and a sensitive antibody-dependent cellular cytotoxicity (ADCC) assay were applied. An assay for bone-marrow colony growth (CFU-GM, BFU-E) inhibition was applied as well. A C1q-binding test was used to detect immune complexes. The lymphocytes of all five patients had the capacity to lyse alloantibody sensitized neutrophils. Neutrophil-bound IgG was found only in one patient. Two patients had neutrophil-reactive antibodies in their serum; in one patient these antibodies were only detectable in the ADCC using the patient's serum to sensitize target cells. However, these antibodies reacted also with lymphocytes, were absorbable with platelets and thus probably were HLA antibodies. The serum of one of these two patients showed complement-dependent CFU-GM and BFU-E inhibition, but the observed inhibition was probably also due to the anti-HLA antibodies present in his serum, as the inhibiting effect disappeared after absorption of the serum with platelets. The serum of only one patient contained low amounts of immune complexes, as measured in the C1q-binding test. Our data suggest that humoral autoimmune mechanisms, such as autoantibodies against neutrophils or neutrophil precursors or circulating immune complexes, do not seem to play an important role in the K-cell lymphocytosis/neutropenia syndrome. The possible role of the expanded K-cell population, and its humoral products (tumour necrosis factor, interferons), in the syndrome is discussed.
研究了体液免疫机制在5例慢性杀伤(K)细胞淋巴细胞增多症患者中性粒细胞减少症发病机制中的作用。为检测患者血液中的中性粒细胞抗体,应用了免疫荧光、细胞毒性和凝集试验以及一种敏感的抗体依赖性细胞毒性(ADCC)测定法。还应用了骨髓集落生长(CFU-GM、BFU-E)抑制试验。采用C1q结合试验检测免疫复合物。所有5例患者的淋巴细胞均有裂解同种抗体致敏中性粒细胞的能力。仅在1例患者中发现了与中性粒细胞结合的IgG。2例患者血清中有中性粒细胞反应性抗体;在1例患者中,这些抗体仅在使用患者血清致敏靶细胞的ADCC中可检测到。然而,这些抗体也与淋巴细胞反应,可被血小板吸收,因此可能是HLA抗体。这2例患者中1例的血清显示出补体依赖性CFU-GM和BFU-E抑制,但观察到的抑制可能也归因于其血清中存在的抗HLA抗体,因为用血小板吸收血清后抑制作用消失。根据C1q结合试验测定,仅1例患者的血清中含有少量免疫复合物。我们的数据表明,体液自身免疫机制,如针对中性粒细胞或中性粒细胞前体的自身抗体或循环免疫复合物,似乎在K细胞淋巴细胞增多症/中性粒细胞减少症综合征中不起重要作用。文中讨论了扩增的K细胞群体及其体液产物(肿瘤坏死因子、干扰素)在该综合征中的可能作用。